| The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials JP Higgins, DG Altman, PC Gotzsche, P Juni, D Moher, AD Oxman, ... BMJ 343, d5928, 2011 | 30958 | 2011 |
| RoB 2: a revised tool for assessing risk of bias in randomised trials JAC Sterne, J Savović, MJ Page, RG Elbers, NS Blencowe, I Boutron, ... bmj 366, 2019 | 18542 | 2019 |
| ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions JAC Sterne, MA Hernán, BC Reeves, J Savović, ND Berkman, ... bmj 355, 2016 | 13303 | 2016 |
| Food, nutrition, physical activity, and the prevention of cancer: a global perspective World Cancer Research Fund, American Institute for Cancer Research American Institute for Cancer Research, 2007 | 2854* | 2007 |
| Assessing risk of bias in a randomized trial JPT Higgins, J Savović, MJ Page, RG Elbers, JAC Sterne Cochrane handbook for systematic reviews of interventions, 205-228, 2019 | 2214 | 2019 |
| Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: a meta-analysis JAC Sterne, S Murthy, JV Diaz, AS Slutsky, J Villar, DC Angus, D Annane, ... Jama 324 (13), 1330-1341, 2020 | 1961 | 2020 |
| ROBIS: a new tool to assess risk of bias in systematic reviews was developed P Whiting, J Savović, JPT Higgins, DM Caldwell, BC Reeves, B Shea, ... Journal of clinical epidemiology 69, 225-234, 2016 | 1841 | 2016 |
| Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials J Savović, HE Jones, DG Altman, RJ Harris, P Jüni, J Pildal, B Als-Nielsen, ... Annals of internal medicine 157 (6), 429-438, 2012 | 1346 | 2012 |
| A revised tool for assessing risk of bias in randomized trials ES Higgins JPT, Sterne JAC, Savović J, Page MJ, Hróbjartsson A, Boutron I ... Cochrane Methods. Cochrane Database of Systematic Reviews 2016 (10 (Suppl 1 …, 2016 | 1333* | 2016 |
| Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis JA López-López, JAC Sterne, HHZ Thom, JPT Higgins, AD Hingorani, ... bmj 359, 2017 | 606 | 2017 |
| WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group. Association between administration of IL-6 antagonists and mortality among patients hospitalized for … M Shankar-Hari, CL Vale, PJ Godolphin, D Fisher, JPT Higgins, F Spiga, ... jama 326 (6), 499-518, 2021 | 541* | 2021 |
| Methods for causality assessment of adverse drug reactions: a systematic review TB Agbabiaka, J Savović, E Ernst Drug safety 31, 21-37, 2008 | 468 | 2008 |
| Revised Cochrane risk-of-bias tool for randomized trials (RoB 2) JPT Higgins, J Savović, MJ Page, JAC Sterne Cochrane handbook for systematic reviews of interventions, 2019 | 454 | 2019 |
| ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ 355: i4919 JA Sterne, MA Hernán, BC Reeves, J Savović, ND Berkman, ... | 449 | 2016 |
| Association between risk-of-bias assessments and results of randomized trials in Cochrane reviews: the ROBES meta-epidemiologic study J Savović, RM Turner, D Mawdsley, HE Jones, R Beynon, JPT Higgins, ... American journal of epidemiology 187 (5), 1113-1122, 2018 | 340 | 2018 |
| Evaluation of the Cochrane Collaboration’s tool for assessing the risk of bias in randomized trials: focus groups, online survey, proposed recommendations and their implementation J Savović, L Weeks, JAC Sterne, L Turner, DG Altman, D Moher, ... Systematic reviews 3, 1-12, 2014 | 336 | 2014 |
| Evaluation of the Cochrane tool for assessing risk of bias in randomized clinical trials: overview of published comments and analysis of user practice in Cochrane and non … L Jørgensen, AS Paludan-Müller, DRT Laursen, J Savović, I Boutron, ... Systematic reviews 5, 1-13, 2016 | 322 | 2016 |
| Empirical evidence of study design biases in randomized trials: systematic review of meta-epidemiological studies MJ Page, JPT Higgins, G Clayton, JAC Sterne, A Hróbjartsson, J Savović PloS one 11 (7), e0159267, 2016 | 275 | 2016 |
| WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group. Association between administration of systemic corticosteroids and mortality among critically ill … JAC Sterne, S Murthy, JV Diaz, AS Slutsky, J Villar, DC Angus, D Annane, ... Jama 324 (13), 1330-1341, 2020 | 263 | 2020 |
| The effects of changes to the built environment on the mental health and well-being of adults: Systematic review THM Moore, JM Kesten, JA López-López, S Ijaz, A McAleenan, ... Health & place 53, 237-257, 2018 | 263 | 2018 |
Jonathan SterneProfessor of Medical Statistics and Epidemiology, University of BristolEmail verificata su bristol.ac.uk
